Latest news with #Wandercraft
Forbes
2 days ago
- Automotive
- Forbes
Renault Is Now A Strategic Partner And Investor In Wandercraft
Sneak peek of the Calvin-40 The Renault Group has finalized a minority investment in the French self-balancing exoskeleton developer Wandercraft. This agreement unlocks new funding and serves as a vote of confidence in the technology that enables people confined to a wheelchair to stand and walk again without the need for crutches or walkers. Furthermore, the Renault Group will leverage Wandercraft's technical expertise to develop a new line of humanoid robots. This strategic partnership is initially focusing on Calvin, a line of next-generation robots for manufacturing operations (a sneak peek of the Calvin-40 is featured above). The intent is for these robots to perform tasks that require handling of loads in body positions that put too much wear and tear on workers' bodies. Finally, the partnership envisions leveraging Renault's assembly expertise to make robots and exoskeletons more affordable and easier to produce at scale. 'We are proud to continue advancing our mission through this strategic partnership. After millions of steps, and numerous awards recognizing our use of AI for good, this move takes us to the next level. As a world-class manufacturer, Renault Group strengthens our ability to produce at scale while increasing access, which remains critical for our soon-to-be customers walking again in Eve. Renault Group also brings tremendous technological synergies and represents our very first customer in a growing list of clients.' - Matthieu Masselin, CEO and co-founder of Wandercraft. 'This partnership with Wandercraft is a forward-looking move. It will allow us to accelerate on automation and to develop robots for our specific auto industrial use, giving us the opportunity to concentrate our people on more value-adding tasks and alleviate operators from painful and non-ergonomics duties. It will drive productivity through the acceleration of production time and cost reduction. In the end, it makes a lot of sense to combine Wandercraft's unique expertise and technology in exoskeletons and robots, with Renault Group's strong industrial capacity and design-to-cost know-how to bring the production of robots at scale' said Thierry Charvet, Chief Industry and Quality Officer of Renault Group. Indeed, Renault Group's trust in Wandercraft appears to be well placed. Wandercraft's self-balancing exoskeleton won the Artificial Intelligence Innovation Award at SXSW 2025. Wandercraft's use of AI was also highlighted in NVIDIA's CEO Keynote speech at CES 2025, Las Vegas. The company was able to compete by placing a mannequin inside their exoskeleton and still won first place in two disciplines at Humanoids 24. Finally, this isn't even the first time an exoskeleton developer has applied their expertise to the world of humanoid robotics. That honor goes to Fourier, which launched the GR-1 humanoid robot five years after releasing their first walking-assist exoskeleton. The Renault Group has chosen not only to invest in Wandercraft but also to partner with them in creating new and more affordable robotic solutions that improve people's lives.
Yahoo
2 days ago
- Automotive
- Yahoo
Renault Group finalises a strategic partnership with Wandercraft, a leader in next generation robotics
PRESS RELEASEJune 6, 2025 Renault Group finalises a strategic partnership with Wandercraft, a leader innext generation robotics Renault Group announces the closing of the acquisition of a minority investment in Wandercraft, a French company with an undisputed leadership in AI-enabled robotic exoskeletons for people with reduced mobility, currently deploying its technology towards mobile robots for industrial uses. This investment comes together with a partnership agreement to develop a family of next generation robots, based on Wandercraft's technology, firstly for Renault Group's own manufacturing operations. The partnership brings Renault Group's industrial expertise to scale up production of Wandercraft's exoskeletons and robots. It will also help Wandercraft open new business opportunities in robotics. Boulogne-Billancourt, June 6, 2025 – Renault Group and Wandercraft announce the closing of a minority investment by Renault Group in Wandercraft, the first company to develop, manufacture and market medical self-balancing exoskeletons. Building on its strong expertise in powerful and reliable exoskeletons, Wandercraft has developed an advanced platform for uses such as manufacturing. Renault Group invests together with Wandercraft's existing shareholders and new investors. Through a commercial partnership agreement, Renault Group and Wandercraft aim to ensure the development of Calvin, a family of next generation robots, firstly for industrial uses. Calvin will allow Renault Group to relieve its workers from painful and non-ergonomics tasks, while reducing production time and thus gaining on productivity. At a later stage, this partnership will also include the industrialization of robots and exoskeletons by Renault Group in order to reduce costs through design-to-cost and scaling — two disciplines in which the automotive industry is well recognized. This will help Wandercraft to bring its new exoskeleton Eve on the market and open new business opportunities in robotics. "This partnership with Wandercraft is a forward-looking move. It will allow us to accelerate on automation and to develop robots for our specific auto industrial use, giving us the opportunity to concentrate our people on more value-adding tasks and alleviate operators from painful and non-ergonomics duties. It will drive productivity through the acceleration of production time and costs' reduction. In the end, it makes a lot of sense to combine Wandercraft's unique expertise and technology in exoskeletons and robots, with Renault Group's strong industrial capacity and design-to-cost know-how to bring the production of robots at scale" said Thierry Charvet, Chief Industry and Quality Officer of Renault Group. 'Renault Group's investment marks a defining moment for Wandercraft. This partnership will boost our ability to build and scale high-impact, low-cost robotics that improve the everyday lives of real people—whether it's helping individuals with disabilities walk or supporting industrial workers through automation — on the factory floor, in clinics and at home. We're proud to combine our technology with Renault Group's industrial excellence to deliver the next generation of mobile robotics' said Matthieu Masselin, CEO and co-founder of Wandercraft. RENAULT GROUPINVESTOR RELATIONS Philippine de 6 13 45 68 39 RENAULT GROUP PRESS CONTACT Rie Yamane +33 6 03 16 35 François Rouget+33 6 23 68 07 WANDERCRAFT PRESS CONTACT Lilly Kofler +1 Jean-Louis Constanza+33 607 529 About Renault Group Renault Group is at the forefront of a mobility that is reinventing itself. The Group relies on the complementarity of its 4 brands - Renault - Dacia - Alpine and Mobilize - and offers sustainable and innovative mobility solutions to its customers. Established in 114 countries, Renault Group sold 2.265 million vehicles in 2024. It employs more than 98,000 people who embody its Purpose every day, so that mobility brings people closer. Ready to pursue challenges both on the road and in competition, the Group is committed to an ambitious and value generating transformation focused on the development of new technologies and services, and a new range of even more competitive, balanced, and electrified vehicles. In line with environmental challenges, the Group's ambition is to achieve carbon neutrality in Europe by 2040. More information: About WandercraftWandercraft deploys the most advanced robotics to help humans. Founded in 2012, Wandercraft is globally recognized for its next-generation exoskeleton technology that safely and reliably helps walking-impaired persons to walk again. Wandercraft has more than 30 patents and 100 Atalante exoskeletons operating in hospitals across four continents. The new personal exoskeleton, Eve, will be marketed in a few months to assist quadriparetic persons in their daily lives. Wandercraft's humanoid exoskeletons collectively take over a million steps each month, fueling a proprietary neural network trained on real-world movement data. This dataset, one of the most advanced in human motion, powers Wandercraft's next generation of exoskeletons and robots, starting with Calvin 40, developed in 40 days as the first of the Calvin family of humanoid robots. Wandercraft believes that robotics should serve the people who need it most. More information: Attachment 20250606_ EN_Renault Group_Press Release Closing WandercraftSign in to access your portfolio
Yahoo
2 days ago
- Automotive
- Yahoo
Renault Group finalises a strategic partnership with Wandercraft, a leader in next generation robotics
PRESS RELEASEJune 6, 2025 Renault Group finalises a strategic partnership with Wandercraft, a leader innext generation robotics Renault Group announces the closing of the acquisition of a minority investment in Wandercraft, a French company with an undisputed leadership in AI-enabled robotic exoskeletons for people with reduced mobility, currently deploying its technology towards mobile robots for industrial uses. This investment comes together with a partnership agreement to develop a family of next generation robots, based on Wandercraft's technology, firstly for Renault Group's own manufacturing operations. The partnership brings Renault Group's industrial expertise to scale up production of Wandercraft's exoskeletons and robots. It will also help Wandercraft open new business opportunities in robotics. Boulogne-Billancourt, June 6, 2025 – Renault Group and Wandercraft announce the closing of a minority investment by Renault Group in Wandercraft, the first company to develop, manufacture and market medical self-balancing exoskeletons. Building on its strong expertise in powerful and reliable exoskeletons, Wandercraft has developed an advanced platform for uses such as manufacturing. Renault Group invests together with Wandercraft's existing shareholders and new investors. Through a commercial partnership agreement, Renault Group and Wandercraft aim to ensure the development of Calvin, a family of next generation robots, firstly for industrial uses. Calvin will allow Renault Group to relieve its workers from painful and non-ergonomics tasks, while reducing production time and thus gaining on productivity. At a later stage, this partnership will also include the industrialization of robots and exoskeletons by Renault Group in order to reduce costs through design-to-cost and scaling — two disciplines in which the automotive industry is well recognized. This will help Wandercraft to bring its new exoskeleton Eve on the market and open new business opportunities in robotics. "This partnership with Wandercraft is a forward-looking move. It will allow us to accelerate on automation and to develop robots for our specific auto industrial use, giving us the opportunity to concentrate our people on more value-adding tasks and alleviate operators from painful and non-ergonomics duties. It will drive productivity through the acceleration of production time and costs' reduction. In the end, it makes a lot of sense to combine Wandercraft's unique expertise and technology in exoskeletons and robots, with Renault Group's strong industrial capacity and design-to-cost know-how to bring the production of robots at scale" said Thierry Charvet, Chief Industry and Quality Officer of Renault Group. 'Renault Group's investment marks a defining moment for Wandercraft. This partnership will boost our ability to build and scale high-impact, low-cost robotics that improve the everyday lives of real people—whether it's helping individuals with disabilities walk or supporting industrial workers through automation — on the factory floor, in clinics and at home. We're proud to combine our technology with Renault Group's industrial excellence to deliver the next generation of mobile robotics' said Matthieu Masselin, CEO and co-founder of Wandercraft. RENAULT GROUPINVESTOR RELATIONS Philippine de 6 13 45 68 39 RENAULT GROUP PRESS CONTACT Rie Yamane +33 6 03 16 35 François Rouget+33 6 23 68 07 WANDERCRAFT PRESS CONTACT Lilly Kofler +1 Jean-Louis Constanza+33 607 529 About Renault Group Renault Group is at the forefront of a mobility that is reinventing itself. The Group relies on the complementarity of its 4 brands - Renault - Dacia - Alpine and Mobilize - and offers sustainable and innovative mobility solutions to its customers. Established in 114 countries, Renault Group sold 2.265 million vehicles in 2024. It employs more than 98,000 people who embody its Purpose every day, so that mobility brings people closer. Ready to pursue challenges both on the road and in competition, the Group is committed to an ambitious and value generating transformation focused on the development of new technologies and services, and a new range of even more competitive, balanced, and electrified vehicles. In line with environmental challenges, the Group's ambition is to achieve carbon neutrality in Europe by 2040. More information: About WandercraftWandercraft deploys the most advanced robotics to help humans. Founded in 2012, Wandercraft is globally recognized for its next-generation exoskeleton technology that safely and reliably helps walking-impaired persons to walk again. Wandercraft has more than 30 patents and 100 Atalante exoskeletons operating in hospitals across four continents. The new personal exoskeleton, Eve, will be marketed in a few months to assist quadriparetic persons in their daily lives. Wandercraft's humanoid exoskeletons collectively take over a million steps each month, fueling a proprietary neural network trained on real-world movement data. This dataset, one of the most advanced in human motion, powers Wandercraft's next generation of exoskeletons and robots, starting with Calvin 40, developed in 40 days as the first of the Calvin family of humanoid robots. Wandercraft believes that robotics should serve the people who need it most. More information: Attachment 20250606_ EN_Renault Group_Press Release Closing WandercraftError in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Fox News
24-05-2025
- Health
- Fox News
AI exoskeleton gives wheelchair users the freedom to walk again
For Caroline Laubach, being a Wandercraft test pilot is about more than just trying out new technology. It's about reclaiming a sense of freedom and connection that many wheelchair users miss. Laubach, a spinal stroke survivor and full-time wheelchair user, has played a key role in demonstrating the personal AI-powered prototype exoskeleton's development, and her experience highlights just how life-changing this device can be. "When I'm in the exoskeleton, I feel more free than I do in my daily life," said Laubach. "It gives me the opportunity to walk around and talk to people at eye level. I don't have to look up at people all the time. "It makes me feel more visible and able to connect with others. One thing I noticed right away, was how inclusive the exoskeleton would be to a wide variety of disabilities. The goal is to have disabled people able to use this exoskeleton to live their daily life out in the world; I can definitely see that happening in the future." Laubach's story is at the heart of Wandercraft's mission: to help people move through the world with greater walking independence and upright mobility. Wandercraft's journey began with a personal challenge. Nicolas Simon, the company's co-founder, saw his own family members struggle with mobility due to Charcot-Marie-Tooth disease, a genetic condition. As a student and robotics enthusiast, Simon wanted to create something that could help his brother and others like him walk again. Alongside Matthieu Masselin and Jean-Louis Constanza, who also had a personal connection to the cause, Simon founded Wandercraft in 2012. Their goal was simple but ambitious: to bring advanced mobility solutions to the estimated 80 million people worldwide who rely on wheelchairs. Wandercraft's first exoskeleton, Atalante X, is already making a difference in over 100 clinics and research centers worldwide. This device, cleared by the Food and Drug Administration (FDA) and approved in Europe, helps patients take over a million steps each month as part of their rehabilitation. It has already helped hundreds regain some mobility and independence. But Wandercraft wanted to go further. The new Personal Exoskeleton protoype, now in clinical trials in New York and New Jersey, is designed for daily life, at home, at work, and out in the community. It uses NVIDIA AI to adapt instantly to each user's movements, providing smooth, stable walking on all sorts of surfaces, from sidewalks to carpets. Users control the exoskeleton with a joystick, making it accessible to people with a wide range of abilities. A big part of Wandercraft's progress comes from its partnership with Nvidia. The team uses Nvidia Isaac Sim, a powerful simulation tool, to test and improve the exoskeleton in virtual environments before real-world trials. They're also exploring Nvidia's healthcare robotics and edge computing platforms to make the device smarter and more responsive. This technology means the exoskeleton can someday keep up with everyday life, walking at a normal pace, crossing streets, and even handling stairs. As Simon puts it, "It's essential for the exoskeleton to be fast enough that it can be used in the real world. By integrating NVIDIA AI into the device, we can someday enable users to walk at an average pace, cross the road, and go up and down stairs." Wandercraft's commitment to improving lives goes beyond just building exoskeletons. In the heart of Manhattan, the company has opened Walk in New York by Wandercraft, a state-of-the-art physical therapy practice and Atalante X walk center located at 345 Park Avenue South. This groundbreaking center is the first of its kind in the U.S. and represents a partnership between Wandercraft and licensed physical therapy professionals to help individuals with neurological conditions move more, move better and move again. At Walk in New York, movement is truly seen as medicine. The center offers personalized screenings with licensed physical therapists, hands-free walking sessions using the Atalante X exoskeleton, and comprehensive neurorehabilitation services. Patients can experience walking again in a safe, professional environment, regardless of their trunk or upper body strength. Each therapy plan is tailored to the individual, and progress is tracked objectively to ensure the best possible outcomes. The technology at Walk in New York goes beyond exoskeletons. The center features virtual reality systems for real-time movement feedback, mirror therapy to promote motor recovery, advanced gait analysis, and immersive environments that make rehabilitation more engaging and effective. Walk in New York is also set to become the hub for Wandercraft's Personal Exoskeleton, where individuals will be able to receive their own devices, undergo training, and access ongoing support as this technology becomes available for everyday use. The center's focus on personalized care and innovation makes it a welcoming space for anyone interested in rediscovering mobility, whether for themselves or a loved one. At Walk in New York, the belief is simple: movement is medicine, and everyone deserves the chance to move through life with confidence and independence. Wandercraft is working toward FDA approval for the Personal Exoskeleton, with hopes of making it available to millions of wheelchair users in the U.S. and beyond. The company is actively recruiting participants for its clinical trials and is committed to making this technology accessible, with plans for Medicare coverage in the future. Are you an adult 18 or older with a complete or incomplete motor SCI at or above the T6 vertebra? If so, you might be eligible for our clinical trial. To participate, you'll need a physically able companion to assist you during sessions. If you don't have someone in mind, don't worry, Wandercraft is creating a volunteer network to help connect trial participants with companions. Both patients and companions should be able to speak English or communicate well with a translator. If you meet these criteria, or if you're interested in volunteering as a companion, you can reach out to Wandercraft by emailing them at clinicaltrials@ Despite all the advances in technology over the past few decades, tens of millions of people still rely on wheelchairs. Wandercraft's Personal Exoskeleton, shaped by the real-life experiences of test pilots like Laubach, is offering a new way forward, one that brings freedom, independence and a renewed sense of possibility. Laubach's story really shows how powerful this technology can be when it is designed with real people in mind. Wandercraft's Personal Exoskeleton isn't just about robotics or AI; it's about helping people stand tall, connect with others, and live life on their own terms. Every step taken with this device brings that vision closer to reality, making the future of mobility feel more hopeful and within reach than ever before. In what ways could AI-driven wearable robotics reshape how we think about disability and independence? Let us know by writing us at For more of my tech tips and security alerts, subscribe to my free CyberGuy Report Newsletter by heading to Follow Kurt on his social channels: Answers to the most-asked CyberGuy questions: New from Kurt: Copyright 2025 All rights reserved.
Yahoo
23-05-2025
- Business
- Yahoo
Health care innovation in NYC helps people walk again and create healthier futures
NEW YORK (PIX11) — Robotics are helping people walk for the first time, and researchers are fighting Alzheimer's and cancer inside the building at the corner of East 26th Street and Park Avenue South in Manhattan. Twenty-one health care innovators call the building home. The wall says Cure because that's the name of the company that connects global leaders in life sciences, digital health, and technology to investors and governments. More Local News The collaboration is designed to build a healthier and more vibrant future. Wandercraft is one of the firms. Its technology has created exoskeletons for people with mobility issues. On Thursday, 33-year-old Zachary Triano was on site to take a giant step in his life. Living with cerebral palsy, he has been in a wheelchair for most of his life. 'I've experienced walking as never before. The robot helps me get the foot down flat and for balance. I've been using muscles I never used before. It's amazing. It's a big deal,' he said. The exoskeleton provides support and assists in movement inside the rehabilitation center. Wandercraft is working on a home version. Triano supplies the inspiration. He saw the technology at a conference three weeks ago. He immediately signed up and has already logged 1,800 steps with the goal of a mile. 'I'm hoping if I take enough steps with this machine that it will teach my brain and I can relearn how to walk,' he said. Seema Kumar is the CEO of CURE. She calls the campus an ecosystem. 'Bringing it all together and putting it under one roof, you create a collision of great ideas that move things forward and accelerate it,' she said. Matthew Masselin is the CEO of Wandercraft. It's a personal mission for him as a friend faces life with mobility issues. 'Things do not happen without relationships and if you do not know each other. Cure is about creating an environment where those relationships can happen,' he said. The official says the campus creates a place where science and dreams can become real with the right financing and support systems. Success can be measured in steps and smiles. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
